NetworkNewsBreaks Archive - Page 1160 of 2081

ThursdayFeb 04, 2021 10:06 am

NetworkNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Announces CannRX Biosciences Partnership

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a U.S.-based cannabis and hemp-branded products company, has entered into a partnership with CannRx Biosciences (“CannRx”). Based in Tel Aviv, CannRX is a leading Israeli cannabis firm focused on the development cannabis-based botanical medicine. The partnership involves using CannRx’s proprietary onset technology, CannTrap, which is a solid nano-particle, water-soluble technology that uses proteins to increase the bioavailability of cannabinoids and terpenes. CannRx works by replicating the body’s sophisticated, protein-based transport system to facilitate improved delivery of active compounds throughout the body; CannRx developed the technology for specific use with cannabinoids. The partnership calls for…

ThursdayFeb 04, 2021 9:45 am

NetworkNewsBreaks – Loop Insights Inc. (TSXV: MTRX) (OTCQB: RACMF) Launches First Enterprise Ecommerce Pilot

Loop Insights (TSXV: MTRX) (OTCQB: RACMF), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick-and-mortar space, today announced the launch of a pilot agreement with Maplin Electronics, the UK’s leading online electronics retailer, to implement Loop’s real-time artificial intelligence analytics platform. “This opportunity with Maplin represents our first enterprise eCommerce retailer, providing Loop with a tremendous opportunity to demonstrate the power of our real-time, artificial intelligence-driven engagement to online customers,” said Loop Insights CEO Rob Anson. “Loop will deliver operational efficiencies for Maplin by providing real-time…

ThursdayFeb 04, 2021 9:22 am

NetworkNewsBreaks – INmune Bio Inc. (NASDAQ: INMB) Featured by M-Vest

INmune Bio (NASDAQ: INMB), focused on developing treatments that target the innate immune system to fight disease, was recently highlighted as a featured company by M-Vest. The business description reads, “Drug candidates, INKmune(TM) and INB03, may be used to treat cancer. XPro1595 targets neuroinflammation as a cause of Alzheimer’s disease. INmune Bio’s product platforms utilize a precision therapy approach, promoting the body’s innate immune response to treat unsolved problems in medicine.” For more details, visit https://nnw.fm/hIxc8 About INmune Bio, Inc. INmune Bio is a publicly traded, clinical-stage biotechnology company focused on developing treatments that target the innate immune system to…

ThursdayFeb 04, 2021 9:16 am

NetworkNewsBreaks – Capricor Therapeutics Inc. (NASDAQ: CAPR) Featured by M-Vest

Capricor Therapeutics (NASDAQ: CAPR), a clinical-stage biotechnology company, was recently highlighted as a featured company by M-Vest. The business description reads, “CAP-1002 consists of allogeneic cardiosphere-derived cells, or CDCs, a unique population of cells that have been shown to exert potent immunomodulatory activity, which alters the immune system’s activity to stimulate cellular regeneration. CDCs have been the subject of over 100 peer-reviewed scientific publications and have been administered to approximately 200 human subjects across several clinical trials.” For more details, visit https://nnw.fm/ghZ82 About Capricor Therapeutics Inc. Capricor Therapeutics is a clinical-stage biotechnology company focused on the discovery, development and commercialization…

ThursdayFeb 04, 2021 9:00 am

NetworkNewsBreaks – AlgoTrader Releases AlgoTrader 6.2 — A More Versatile Trading Experience

AlgoTrader has announed the release of AlgoTrader 6.2, designed to be a more versatile, efficient trading experience. The updated release features impressive improvements that can be seen throughout the trading workflow experience, including improved visualizations, increased connectivity and new execution algorithms. Other highlights of the new release include enhanced trading data and performance visualizations; the addition of Binance Futures, Poloniex spot and German stockbroker Sino; a new identity and access-management system; an improved API key management system; the addition of four execution algorithms; and the ability to trade multiple accounts on the same exchanges, all at the same time. AlgoTrader…

WednesdayFeb 03, 2021 3:54 pm

NetworkNewsBreaks – Why HYB Holding Corp. (HYBG) Is ‘One to Watch’

HYB Holding (OTC: HYBG), through its Mediscan Inc. subsidiary, created a cloud-based software for ultrasound technology that reconstructs the analog two-dimensional grayscale visual image into a digital three-dimensional, high-definition quantifiable format. A recent article discussing the company reads, “The Mediscan software application dramatically increases the medical professional’s ability to use existing ultrasound devices at the point of care to derive meaningful data-driven clinical evaluations of a patient’s pathology or trauma, facilitate support for treatment options, monitor the patient’s ongoing progress or regress, and document compliance with required protocols and procedures. The Mediscan application also integrates with all popular EMR systems.”…

WednesdayFeb 03, 2021 3:12 pm

NetworkNewsBreaks – TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) Featured in Forbes Article

TAAT(TM) Lifestyle & Wellness Ltd. (CSE: TAAT) (OTCQB: TOBAF) (FRA: 2TP2) has announced that an article profiling the company was published earlier today by Forbes, marking the first national mainstream media coverage of TAAT(TM) in the United States. In the piece, Forbes contributor Amanda Siebert, who primarily covers media stories in the “Vices” category, summarizes her interview with TAAT(TM) CEO Setti Coscarella, in which Coscarella shares his professional background and journey to his current role. Additionally, the article features Coscarella’s comments on recent events relating to the company including its engagement with consumer packaged goods (“CPG”) sales agency CROSSMARK. “After approximately…

WednesdayFeb 03, 2021 1:32 pm

NetworkNewsBreaks – iClick Interactive Asia Group Limited (NASDAQ: ICLK) Provides Update on Successful Partnership with Instant Noodle Brand Luo Ba Wang

iClick Interactive (NASDAQ: ICLK), an independent online marketing and enterprise data solutions provider in China, is working with and Luo Ba Wang, an Enterprise Solutions client. iClick recently reported on the successful partnership with the emerging and innovative instant noodle brand in China. Using iClick's integrated solutions, Luo Ba Wang has established and strengthened its brand awareness; the announcement noted that in less than one month, Luo Ba Wang generated 30 million views. The partnership between iClick and Luo Ba Wang has had several objectives, including to help the brand identify and target potential consumers, build a mini-program store that provided Luo Ba Wang…

WednesdayFeb 03, 2021 1:22 pm

NetworkNewsBreaks – Knightscope Inc. Reaches 19K Investor Mark

Knightscope, a developer of advanced physical security technologies utilizing fully autonomous security robots (“ASRs”), has announced that that it now has 19,000 investors. The announcement, in which Knightscope expressed its gratitude to its investors for their support, comes a few short weeks after the company reported to have closed over 18,000 investors since its inception. The update reads, “To look back to early 2013 when we couldn't get a single person to believe in us, we are beyond humbled on how far we have been able to get and how much we've achieved - because of your kind and gracious…

WednesdayFeb 03, 2021 1:12 pm

NetworkNewsBreaks – Merus N.V. (NASDAQ: MRUS) Secures $138M in Underwritten Public Offering

Merus (NASDAQ: MRUS), focused on the development of innovative, full-length multispecific antibodies, has closed an underwritten public offering of 5,575,757 shares of common stock, including an additional 727,272 shares per the full exercise of the over-allotment option granted to the underwriters. Merus secured approximately $138 million in gross proceeds, with each of the shares sold at the public offering price of $24.75. The company intends to use the proceeds to advance clinical development of its product candidates, for preclinical research and technology development, as well as for working capital and general corporate purposes. ROTH Capital Partners acted as co-manager for…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks